These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

970 related articles for article (PubMed ID: 16802568)

  • 21. Hyperhomocysteinemia, paraoxonase concentration and cardiovascular complications in Tunisian patients with nondiabetic renal disease.
    Kerkeni M; Letaief A; Achour A; Miled A; Trivin F; Maaroufi K
    Clin Biochem; 2009 Jun; 42(9):777-82. PubMed ID: 19233152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events.
    Vianna AC; Mocelin AJ; Matsuo T; Morais-Filho D; Largura A; Delfino VA; Soares AE; Matni AM
    Hemodial Int; 2007 Apr; 11(2):210-6. PubMed ID: 17403173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A; Naderi AS
    Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What is the meaning of homocysteine in patients on dialysis?
    Silva de Almeida CC; Guerra DC; Vannucchi MT; Geleilete TJ; Vannucchi H; Chiarello PG
    J Ren Nutr; 2011 Sep; 21(5):394-400. PubMed ID: 21439851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased plasma homocysteine concentration in patients with chronic renal failure.
    Chauveau P; Chadefaux B; Coudé M; Aupetit J; Hannedouche T; Kamoun P; Jungers P
    Miner Electrolyte Metab; 1992; 18(2-5):196-8. PubMed ID: 1465057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
    Helal I; Smaoui W; Hamida FB; Ouniss M; Aderrahim E; Hedri H; Elyounsi F; Maiz HB; Abdallah TB; Kheder A
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):59-62. PubMed ID: 20061694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does hemodiafiltration improve the removal of homocysteine?
    Badiou S; Morena M; Bargnoux AS; Jaussent I; Rodriguez A; Leray-Moragues H; Chalabi L; Bosc JY; Canaud B; Cristol JP
    Hemodial Int; 2011 Oct; 15(4):515-21. PubMed ID: 22111820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Risk factors for atherosclerotic vascular disease in patients on maintenance hemodialysis--with especial respect to reverse cholesterol transport system and hyperhomocysteinemia].
    Kimura H; Yoshida H
    Rinsho Byori; 2002 Aug; 50(8):793-801. PubMed ID: 12373816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased prevalence of hyperhomocysteinemia in cervical artery dissection causing stroke: a case-control study.
    Benninger DH; Herrmann FR; Georgiadis D; Kretschmer R; Sarikaya H; Schiller A; Baumgartner RW
    Cerebrovasc Dis; 2009; 27(3):241-6. PubMed ID: 19176957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between plasma homocysteine concentrations and cardiac hypertrophy in end-stage renal disease.
    Blacher J; Demuth K; Guerin AP; Vadez C; Moatti N; Safar ME; London GM
    J Nephrol; 1999; 12(4):248-55. PubMed ID: 10493568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homocysteine and progression of coronary artery disease.
    Skibińska E; Sawicki R; Lewczuk A; Prokop J; Musiał W; Kowalska I; Mroczko B
    Kardiol Pol; 2004 Mar; 60(3):197-205. PubMed ID: 15156215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dimercaptosuccinic acid for the treatment of hyperhomocysteinemia in hemodialysis patients: a placebo-controlled, double-blind, randomized trial.
    House AA; Eliasziw M; Urquhart BL; Freeman DJ; Spence JD
    Am J Kidney Dis; 2004 Oct; 44(4):689-94. PubMed ID: 15384020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Intravenous folinic acid and vitamin B12 supplementation and homocysteine concentration in hemodialysis patients].
    Corghi E; Patrosso C; Bamonti F; Baragetti I; Novembrino C; Lando G; De Franceschi M; Buccianti G
    G Ital Nefrol; 2002; 19(3):301-7. PubMed ID: 12195398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leptin as a marker of nutrition and cardiovascular risk in peritoneal dialysis patients.
    Aguilera A; Bajo MA; Rebollo F; Díez JJ; Díaz C; Paiva A; Codoceo R; Selgas R
    Adv Perit Dial; 2002; 18():212-7. PubMed ID: 12402621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of mesna on plasma total homocysteine concentration in hemodialysis patients.
    Urquhart BL; Freeman DJ; Spence JD; House AA
    Am J Kidney Dis; 2007 Jan; 49(1):109-17. PubMed ID: 17185151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesna for the treatment of hyperhomocysteinemia in hemodialysis patients.
    Cutler MJ; Urquhart BL; Freeman DJ; Spence JD; House AA
    Blood Purif; 2009; 27(3):306-10. PubMed ID: 19270449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations of plasma homocysteine concentration in subjects with type 2 diabetes mellitus.
    Abdella NA; Mojiminiyi OA; Akanji AO; Moussa MA
    Acta Diabetol; 2002 Dec; 39(4):183-90. PubMed ID: 12486492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between creatinine clearance and plasma homocysteine levels in predialytic chronic renal failure patients.
    Widiana IG; Suwitra K
    Acta Med Indones; 2004; 36(1):15-8. PubMed ID: 15931697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular risk assessment and homocysteine and leptin levels in peritoneal dialysis and hemodialysis patients.
    Bekpinar S; Unlüçerçi Y; Genç S; Türkmen A
    Adv Perit Dial; 2005; 21():80-4. PubMed ID: 16686291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac troponins and left ventricular hypertrophy in hemodialysis patients.
    Petrović D; Obrenović R; Stojimirović B
    Clin Lab; 2008; 54(5-6):145-52. PubMed ID: 18780659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.